Abstract
The ‘typical’ trajectory of a person with cancer has been from diagnosis, through treatment, and towards cure (life) or the end of life (death). Yet, cancer survivorship as a social practice is no longer contained by such neat categorisations. Much of the lived experience of cancer now centres on: living with, rather than beyond, disease; the perpetuity of treatment rather than the spectre of disease; and, making sense of incurability. Using a solicited diary methodology, in this article the authors seek to chronicle life with cancer for those living in the in-between – the often-overlooked lives of incurable survivors. In the analysis of survivors’ diaries, the authors argue for an emphasis on the phenomenology of waiting and sociological exploration of how clinical prognostications affectively haunt the present. This, they posit, will further sociological understandings of the lived experience of affliction and care, especially within relations of chronicity and perpetuity, in this case focusing on advanced cancer and the steadily changing oncological milieu.
Introduction
Cancer, as an illness experience and site of caring relations, is quickly evolving. Technological advances, including developments in immunotherapy, are both practically and discursively inflecting the landscapes of cancer survivorship (Mellman, Coukos, & Dranoff, 2011; Rosenberg, Yang, & Restifo, 2004). Hopes for advances in life expectancy, cure and remission rates are high despite the fact that overall, the rate at which cancer is ‘cured’ has seen relatively little change over the last 30 years vis-a-vis therapeutic investment (Hanahan, 2014; Potti, Schilsky, & Nevins, 2010). Yet, curative trajectories remain the cultural and biomedical foci – often leaving less space for critical sociological reflection on what a life with cancer looks and feels like in an ongoing sense (for exceptions see Bell, 2013; Jain, 2007). The discourse of cancer survivorship often excludes the (growing) cohort of people who are living with, rather than ‘beating’ or surviving beyond, cancer (Haylock, 2010), marginalising (however unwittingly) these ‘incurable survivors’ who defy neat oncological categorisation. More broadly, the enduring medical and cultural emphasis on ‘cure’ often tends to overshadow the lived experiences of illness, affliction and care including such themes as the inevitability of ageing, decline and, eventually, our own mortality (though see Charmaz, 1990; Locock, Ziebland, & Dumelow, 2009). These themes, however, acutely structure the daily experience of those living with advanced cancer, the ‘incurable survivors’ whose existence sits incongruously with dominant medical and cultural discourses.
In this study we explore what it is like to live with advanced cancer in the contemporary milieu, day-to-day, including: the affective pervasiveness of incurability; the dynamics of waiting with prognosis; and the collective atmosphere of questionable survivorship at the nexus of biomedical expertise and everyday life. Building on the considerable work on the social dimensions of cancer (e.g. Bell, 2010; Kaiser, 2008; McKenzie & Crouch, 2004), we offer a temporally sensitive investigation of the experience of questionable survivorship using qualitative solicited diaries. While a solicited diary approach, which allows participants to chronicle and narrate their everyday lives, feelings, thoughts and dilemmas, has been used in a range of contexts including complementary and alternative medicine, experiences of back pain and women’s health (Broom, Kirby, Adams, & Refshuage, 2015; Broom, Meurk, Adams, & Sibbritt, 2014; Broom & Tovey, 2008), this study represents the first time this methodology has been used in the specific context of cancer survivorship. This approach, we posit, offers a nuanced, participant-led and temporally sensitive way to explore the contemporary experience of cancer survivorship, amplifying, in particular ways, the ‘voices’ of our participants and the undulations and fluctuations of their day-to-day lives. As we present below, this reveals critical insights into the experiences of this often-concealed group (i.e. ‘incurable survivors’), existing between the hopes of the curative milieu and the mortal inevitability of the end of life. As medical oncology gains momentum amidst widely publicised (hopeful) transformations and new curative possibilities, there is an important continuing role for social scientists to articulate the importance of the everyday in life with cancer and, more broadly, in relation to affliction, decline and unavoidable human mortality.
Background
While cancer has been the focus of much sociological and social scientific scholarship over the past two decades (see especially Bell, 2010, 2013; Kaiser, 2008; McKenzie & Crouch, 2004), such literature often focuses at the intersection of particular cancers with individual biographies (e.g. prostate: Chapple & Ziebland, 2002; lung: Chapple, Ziebland, & McPherson, 2004; breast: Broom, 2001; Saiillant, 1990) or on its social reception (e.g. Seale, 2001, 2002). Fewer studies have explored the broader landscapes of survivorship (for exceptions see Bell, 2013; Frank, 2003; Sinding & Gray, 2005; Stacey, 1997; Stacey & Bryson, 2012), and even fewer have explored survivorship as a social practice and the dynamics of advanced disease therein (though see Bell, 2013; Jain, 2007; Sinding, Gray, Fitch, & Greenberg, 2002). This remains an extraordinarily fertile area for sociological investigation, with contemporary shifts offering new landscapes of cancer chronicity (see Tritter & Calnan, 2002), with the increasing stretching of subjects’ lifespans accompanied by longer and longer periods with disease (Feuerstein, 2007). Many of those living with cancer encounter considerable ontological uncertainty (i.e. might a cure emerge?), precarious knowledge (i.e. will my cancer remain incurable?) and associated affective dilemmas (i.e. how does one live with incurability, or can/should one attempt to transcend disease?). Here we consider the lived experiences of waiting, clinical knowing and cultural normativities around illness (Del Vecchio-Good, Manuakata, Kobayashi, Mattingly, & Good, 1994; Finerman & Bennett, 1995) that are articulated in the day-to-day undulations of disseminated cancer.
Waiting
Some previous scholarly work has focused on the intersection of affect with temporality in relation to health and illness, especially around the heightened sense of vulnerability emergent from predictive screening (Gillespie, 2012; Sachs, 1995, 1996; Shostak, 2010) and the use of biomarkers to gauge both predisposition to, and remission from, disease (Bell, 2013; Novas & Rose, 2000). Other scholarship has drawn attention to the distinction between ‘objective’ clock time, by which disease progression is clinically assessed, and the ongoing flux of ‘subjective’ time that characterises patients’ experiences of illness (Toombs, 1990). In the context of cancer, some scholars have eloquently elucidated the ‘creepiness’ of cancer (Jain, 2007) and its ‘queer’ temporality (Stacey & Bryson, 2012), whereby the past and future are reconfigured through the prospect of ‘living in prognosis’ (Jain, 2007). However, between past and future, there has been less attention to the dynamics of waiting in the present amidst life-prolonging cancer treatment, and (incurable) survivorship (though see Del Vecchio-Good et al., 1994). The promises and actualities of cancer care – the rapidly evolving possibilities for treatment – mean that waiting in itself has become increasingly important to the lived experience of cancer. The impact of waiting has been an underexplored aspect of the phenomenology of illness and/or affliction. What is waiting in such circumstances; is it for disease to progress; to feel better or to not feel worse; for a dreaded reality to emerge or for spontaneous remission instead; to be the 1% who achieve remission; to survive or to not survive; or, to stop waiting and start living? And what can we glean from the broader cultural resistance to waiting in advancing our understanding of contemporary experiences of cancer?
Importantly, waiting does not happen in a somatic or contextual vacuum but rather amidst a cultural, political and economic climate and broader social relation to time (Adam, 1990; Nowotny, 1994; Schweizer, 2008; see also Hage, 2009; Urry, 2012). According to some, the ‘art of waiting’ has become socially and culturally devalued; it is no longer valued as a social practice or form of virtue and is often positioned, instead, as antithetical to the productive self (see Schweizer, 2008). In On Waiting, Schweizer (2008) notes: ‘[t]he person who waits is out of sync with time, outside of the moral and economic community of those whose time is productive and synchronized or whose time need not – in the habit of velocity – be experienced at all’ (2008, p. 8). Waiting, in contemporary terms, is enforced passivity, an expulsion from the ‘productive’ citizenry, where the passage of time, uninterrupted, recedes into background of the taken-for-granted. Unlike uncertainty, which entails an epistemological orientation towards knowledge, waiting is an embodied and social practice, which infuses our unconscious affect and pervades questions around expectation, expertise and authority (Adam, 1990, p. 122). In cancer, waiting to see what ‘it’ does renders disease a discrete biophysical process, distinguishable from self. Waiting calls into question the boundaries between persons, disease, affect and expertise. The phenomenology of waiting, then, is subsumed within (and offers challenges to) logics about the course of disease, pathology, intentionality and inevitability; it is disciplined, operates within structures of power and authority, and captures forms of agency and resistance evident in the everyday (cf. Foucault, 1977; see also Hage, 2009). Embedded in, and articulated by, waiting are relational practices of surveillance and domination within the medical milieu, legitimate (and illegitimate) claims to knowledge, truth and the course of things/disease. Waiting is thus a personal and interpersonal struggle with the discursive atmosphere of expertise and authority, truth and fallacy, sickness and wellness, hope and hopelessness, being and becoming.
Clinical hauntings
Waiting as a social practice occupies the clinical, the embodied, the affective and intuitive; but is simultaneously informed, occupied, even possessed itself. In this sense Avery Gordon’s (2008, 2011) work on hauntings helps illuminate the affective dynamics produced by and in disease, and in relation to clinical authority. She describes her approach to hauntings as such:
I used the term haunting to describe those singular and yet repetitive instances when home becomes unfamiliar, when your bearings on the world lose direction. … Haunting raises specters, and it alters the experience of being in linear time, alters the way we normally separate and sequence the past, the present and the future. (Gordon, 2008, p. xvi)
Elsewhere, she elaborates:
… haunting [is] precisely the domain of turmoil and trouble, that moment (of however long duration) when things are not in their assigned places, when the cracks and the rigging are exposed … when easily living one day and then the next becomes impossible, when the present seamlessly becoming the future gets entirely jammed up. … Haunting … refers to this socio-political-psychological state when something else, or something different from before, feels like it must be done, and prompts a something-to-be-done. (Gordon, 2011, pp. 2–3)
As we illustrate below, Gordon’s elaboration of hauntings is eerily pertinent to the experience of incurability in cancer. The spectre of disease, as it were, makes its presence known; yet knowledge of its existence is embedded in structures of biomedical expertise and authority. Cancer-as-a-lived-experience often jars with cancer-as-a-clinically-known-biophysical-process, especially where incurable diagnoses and terminal prognostications of oncologists sit in tension with the hopeful anticipations of their patients (Kenny et al., under review). Here, the notion of hauntings draws attention to the modes of knowing, which in oncology include a range of techniques of visualisation and surveillance. As we explore below, waiting with surveillance often entails a juxtaposition of embodied experience and clinical expertise – a form of biomedical haunting of and in the everyday – that foregrounds disease as known and articulated by oncologists, while the emotional life of the person recedes into the background. As a result, the clinical hauntings provoked by advanced cancer can render a life not worth living unrecognisable, and can make securing more life/time necessarily worthwhile. Day-to-day experiences illustrate practices of resistance and transcendence of such spectres, with the lived experience of cancer importantly involving other forms of knowing and raising other possibilities. We articulate this dynamic of waiting and (clinical) hauntings through a temporal methodology, which reveals the tussles between normative influences over time, and between moments in illness, wellness and care.
Methods
Data collection and sample
The use of diaries as a means of collecting data is an established methodological tool (Broom & Tovey, 2008; Elliott, 1997; Jones, 2000; Zimmerman & Wieder, 1977). While researcher journals have long been an accepted source of qualitative data for health research (Jacelon & Imperio, 2005; Jones, 2000), they are less often used in the social sciences (though see Broom & Tovey, 2008; Broom et al., 2014, 2015). In contrast to in-depth interviews or focus groups, the format of maintaining a solicited diary encourages the participant to focus on daily activities and upon reflections she or he values. Although diaries may lack the dialogical complexities and probing allowed in verbal communication, they also allow an examination of seemingly mundane day-to-day thoughts, processes and undulations (Elliott, 1997; Zimmerman & Wieder, 1977). This method has been used in feminist research to access the content of daily life for women and to transcend the potential artificiality and power dynamics of face-to-face interviews (see Hampsten, 1989). A significant benefit of personal diaries is the temporal insight they offer, allowing for flexibility and variation in the narratives presented (Meth, 2003). Solicited diaries may also offer empowerment for participants. Indeed, our participants often commented that maintaining the diary was a useful experience, offering pause for reflection and expression of emotions (Meth, 2003).
This article draws on solicited diaries which constituted one component of a broader research programme on cancer survivorship. Ethics approval was gained through a large metropolitan hospital. In an earlier phase of our research we undertook 80 interviews with people living with cancer. Of those we interviewed, we asked 23 participants to complete a hard copy, paper-based diary over one month. In selecting people to take part we aimed to capture some degree of spread according to cancer type, gender (7 women; 8 men) and age (42–75 years), although the priority was exploring the insights of those living in the in-between of clinical categorisations (i.e. neither clearly curative nor palliative). Fifteen participants completed and returned their diary; eight participants either discontinued for reasons of ill-health, discomfort, did not send the diary back, or died during the diary phase. Diaries were returned by mail, de-identified and transcribed in full, and participants were informed and thanked via phone when we received the returned diary. Excerpts are here identified by pseudonym, cancer type and age bracket in order to preserve anonymity. On average, participants wrote 3000 words (ranging up to 6000+). While many themes explored through the diary questions are continuous with aims of the broader study, this article reports on data exclusively from the solicited diaries. Figure 1 shows the diary template and instructions, Figure 2 contains the diary questions, which were posed daily over the course of the month. Through the diaries we sought to explore such questions as: How does cancer shape participants’ everyday lives? How is uncertainty (prognostic, ontological) experienced by the participants, both in-the-moment and over time? What are the impacts of disease, treatment and side-effects, and how do participants make sense of these in their lives and (evolving) social relationships? How are clinical interactions, knowledge and expertise experienced and what are the implications therein?

Diary template and instructions to participants.

Diary questions (repeated daily).
Data analysis
The methodology for this project draws on the interpretive traditions within qualitative research. Data analysis was based on four questions adapted from Charmaz’s (1990) approach to social analysis: What is the basis of a particular experience, action, belief, relationship or structure? What do these assume implicitly or explicitly about particular subjects and relationships? Of what larger process is this action/belief a part? What are the implications of such actions/beliefs for particular actors/institutional forms? We approached the analysis of diaries thematically, systematically reading through each diary, writing notes, discussing ideas with colleagues and noting emerging patterns within the data collected. The analysis was driven by the first two authors (Broom and Kenny), who read through the diaries several times to identify key themes, test their validity and develop them further. We each sought to retain the complexity of the respondents’ experiences, documenting atypical cases, conflicts, and contradictions within the data. Once emerging themes were established, we searched the diaries for related comments, employing constant comparison to develop or complicate these themes further. The final step involved revisiting the literature and seeking out conceptual tools to make sense of the patterns that had emerged from the data.
Results
Terminal entanglements
Across the diaries it was clear that living with advanced and/or incurable cancer fundamentally challenged participants in their everyday lives, offering a mix of contradictory and constantly changing emotions and experiences. One prominent feature of these diaries was the practice of forgetting, of disentangling the self from the spectre of cancer. This was situated between being constantly ‘drawn back in’ while also trying to ‘take one’s mind off’ cancer, as Audrey, in her diary, reflects on below. This illustrates some of the pervasive affective tensions encountered – including that between dread and hope – as Audrey imagines and feels her disease, in her body, day-to-day. The anxiety is palpable, as are her ongoing efforts to transcend it:
Day 1: Yoga and meditation. Keeping positive … yoga & meditation, which is great, takes your mind off everything.
Have a cold & a few aches & pains. Every little thing you think about is as if the cancer is going somewhere else [in your body] …
Thinking about upcoming scan. Hate them. [Concerned] that it will be bad.
Tired – when I woke up [I was] thinking a lot about cancer …
It’s always seems [sic] to be in the background you can be busy doing lots of things [but] when you stop it’s there. Thinking about my upcoming scan on my lung nodules …
Its [sic] there in the background your mind keeps taking you there. Did yoga & meditation today, feels good … Fear of cancer returning …
Anxious today. Had chest CT scan checking on growth of lung metastases … Hate these days as we seem to live day-to-day & scan-to-scan …You try to put it out of your mind but [you] seem to be drawn back in. (Female, 60–69, with Metastatic Adenoid Cystic Carcinoma/Head and Neck Cancer)
The waiting–transcending dialectic dominates Audrey’s narrative, illustrating the tension between waiting for future clinical prognostic updates (which promise either good news and relief or bad news and greater anxiety), while also trying to live in the meantime – to do more than just wait. Here we see a latent normativity around the passivity of waiting and the attempt, instead, to ‘keep positive’ by ‘put[ting] it out of your mind’.
The difficulty of ‘forgetting’ cancer and the omnipresence of clinical prognostications was articulated by Jack, for whom a future PET (positron emission tomography) scan was ‘hanging over him’, not allowing him to ‘get away from’ his cancer:
Day 26: … tomorrow will be a big day – my 3-month PET scan … tell me how I have progressed. Hoping I am in remission/recovery … Just concentrating on today!
Had a restless night worrying about my PET scan today … Hopefully I will have a shrinking or no-sign of my tonsil tumour or no other signs in my body of further cancer … The doctor was really good, she was frank about what they might uncover but at the same time hopeful of a good result. It put me at ease. A big day – perhaps one of the biggest in my life.
Had a bad night – awake a lot … I am freaking out a bit about the scan and I feel very anxious. … Just concentrating on everyday things around the house, but feeling pretty out of sorts, and a bit panicky inside – anxious – and trying to de-stress.
… I know this week I will be anxious waiting for the scan results … Sometime it’s good to get away from cancer. I have good solid thoughts about the future. Where we will be and what we want to do, which is good. (Male, 50–59, with Metastatic Tonsil Cancer)
Audrey, Jack, and other participants, articulate a complex mix of waiting and restlessness, but also resistance to being subsumed by the dread and unease produced by their prognosis. Waiting provoked anxiety, with impending scans an ever-present reminder of the presence (and progression) of their disease.
For some participants, like Ellen, cancer was ‘present’ only through her treatments; she experienced no symptoms or pain and her cancer had no visible or recognisable presence. For Ellen, the spectre of cancer followed her home from the halls of the hospital. Her appointments thus functioned as a revisiting, reminding her of her fate and her own mortality:
Day 1: … As I have no pain, cancer is not foremost in my mind.
Sometimes I wonder how long I’ll be around. Who knows …
Tired. Some nights I wake up at 2–3am and can’t get back to sleep for no reason.
Always appointments. etc. to remind you that you had an illness.
Out of sorts today, feel a bit down. I was told you can get like this the week after chemo. It’s the first time I have felt like this …
I wish I had more energy …
I’m not ready to turn up my toes & leave this planet, just yet. I have too many things to do & people to see. Especially to see my grandchildren grow up.
You think about doing something in the future & then you think, well I hope I’m still here & in good health.
Well I’m off to the hospital for another CT scan … Hopefully the tumors will have shrunk further … just wish I didn’t have to go through this.
Hospital cancelled my appointment for Thursday, they’ve deferred it til [a later date], beginning to think my social life is my hospital visits …. wondering now what is ahead of me … (Female, 70–79, with Advanced Neuroendocrine Cancer)
For Ellen, the experience of cancer was defined, in part, by the absence of any physical symptoms of cancer, which she equated, primarily, with pain or impairment. Instead, hospital appointments, scans and the logistics of care dominated her experience. We note that it is not our purpose to dismiss the clinical encounter, nor the potency of oncological technologies of visualisations. Instead, we wish to highlight how expertise can be enabling/disabling, helpful/disruptive, contributing to the complex mix of desires and emotions that circulate around cancer. For participants, the interplay of waiting and bodily surveillance produced complicated affective tensions around the omnipresence of disease – of its constancy ‘in the background’, its presence ‘always there’ and its interruption of just being (see Sinding et al., 2002). This participant-led critique was about more than the disenfranchisement of advanced cancer – disease ‘caught too late’, people with few ‘hopes for survival’ – but rather about surviving (or more accurately living) amidst the (affective and biophysical) circulation of disease, oncological encounters and care. In this sense, biomedical surveillance offered a ghostly presence – a clinical haunting – of the everyday, raising questions around what it is doing (growing/shrinking), positioning cancer as separate from the person, and requiring constant engagement of biomedical expertise as its progression was anticipated from appointment to appointment. One response to this set of tensions was to seek out normalcy; to live one’s life alongside cancer.
Normality and normativity
Each of the participants’ diaries illustrated various attempts to find and reclaim a sense of normalcy within their daily lives. For Jack, the search for normalcy became – somewhat ironically – an extensive and thoroughgoing activity. In contrast to the pervasiveness of waiting and clinical prognostications, Jack sought to reclaim an explicit sense of living. This was articulated through a series of dialectics: ‘getting on with it/being in the here and now’, ‘remembering/forgetting’ and so on. ‘Successful’ living with advanced cancer was thus often contradictory; imbued with absence/presence, preoccupation/transcendence and dread/hope:
Day 1: Positive emotions but still focussed on what I need to do to get better.
I do think more about to live life with greater fulfilment.
… Trying to spend a normal Saturday.
Still feeling incredibly tired today, I need to rest. Thought about the tiredness, but realised I am not going backwards anymore – I just have days where I don’t progress in my recovery. I am looking forward to getting my life back to normal the best I can. Cancer makes you realise that your every day, humdrum life is yours and valuable when something (cancer) tries to take it away!
You think about it [cancer] all the time, it can be good or bad …
Wanting to get on with life but realise I have to concentrate on the here and now.
Want to be back to my normal self and not think about cancer – but I know that is a while away yet. Patience!
In a good mood and thoughts of it’s [sic] not so bad and I am learning to live with cancer and deal with the uncertainty …
I definitely feel I am looking forward to living beyond cancer.
… Looking forward to not thinking about it, but at the same time I don’t want to forget what has happened. A lovely warm spring day – life is precious.
Feeling a bit low as I start the scans to see how the cancer has progressed – or not. I don’t like living with cancer …
… learning to give life for everything and not make cancer the centre of the universe. Feeling resilient! (Male, 53, with Advanced Tonsil Cancer)
The challenges of finding a way to live with cancer were accompanied, for many participants, by struggles around how to prevail over it, if not at the somatic level then at the register of normativity. As is the case with many forms of disease or affliction, living with cancer entailed struggles over virtue, honour, being a ‘successful’ subject of terminal or advanced disease (Steinberg, 2015) and finding an idealised ‘normal’ between vigilance and worry (Sinding & Gray, 2005). What participants could ‘achieve’, whether and what kind of ‘goal’ might be useful and the nature of their responsibility to others around them all presented different sites of normative struggle. Dean articulates these dilemmas around ‘fighting’ and the difficulties of goal-setting and living in his (usual) disciplined fashion:
Day 1: I am struggling with achieving my goals … With having cancer I have found myself saying to myself ‘F’ [fuck] it … but I hate it that I am losing the discipline … Frustrating!
… there is great honor [sic] in fighting & by living through cancer but it is considered failing if you die. There is no honourable way of dying from cancer!!
I need to do more to fight cancer. I am not sure how I feel about this …
… If I did everything that everyone thinks I should do to tackle cancer, that is all I would be able to do morning to night. It is difficult to get the balance right and satisfy all your loving supporters. (Male, 42, with Advanced Neuroendocrine Cancer)
While seeking normalcy and ‘finding balance’ was a stated ambition across almost all of the diaries, the normative expectations surrounding those living with cancer imputed heavy responsibilities. In drawing attention to the lack of an honourable exit from a life with cancer, Dean highlights a sense of guilt and responsibility; a moral framing of the subject of illness, their responsibilities to those around them, and the pressure to be a good subject despite the circumstances. Thus Karl expresses the desire to ‘provide’ for his family despite the uncertain course of his cancer:
Day 9: I do think about my longevity – 1 year, 5 years, 10, … The cancer I have is aggressive … My main focus is to see the rest of my family through school – plus I also think about long-term happenings. Apart from cancer related issues, having cancer has made me think about passing on, life after death, etc. I will go into a big sleep. When will I wake up? Where will I be? When? I want to make sure I leave everything in a state that my family is looked after. (Male, 50, with Advanced Brain Cancer)
Across many participants’ reflections, the desire to achieve the normative vision of cancer survivorship persisted despite high levels of uncertainty around their own disease trajectories. However, the uncertainty about the future that accompanies living with advanced or incurable cancer casts treatment – and its various side-effects – in a new light as treatment becomes not a means to cure but an integral part of living with cancer in an ongoing sense.
‘… it is like a disease by itself’: Side-effects, suffering and the valorisation of longevity
One of the consistent themes revealed in the diaries was the challenge of living with the consequences of therapeutic regimens, rather than (actual or anticipated) symptoms of the disease itself. While the clinical focus was perceived to be staving off disease, this was often only part of the focus of participants. This is central to the survivorship experiences of people who are not candidates for curative treatment. The tolerability of illness was transposed into a matter of tolerating intervention (and its often diminishing returns). The rise of targeted therapies and experimental immunotherapy drugs for a wide range of cancers has introduced a (sometimes dramatically life-extending) new set of possibilities, but also, forms of suffering in cancer as illness experience. For several of the participants, the central struggle was assessing whether life was indeed worth living in the context of the side-effects of these emerging (targeted) interventions. Often perpetual, unexpected and certainly debilitating treatment side-effects raised daily questions about the purpose of life and the dynamic of waiting (and suffering) therein, especially when the option of simply waiting for treatment to end – for their cancer to be ‘cured’ – was foreclosed:
Day 1: … as soon as one is diagnosed with cancer … your life basically [r]evolves around the disease – scans, blood tests, MRI’s, medical appointments, dealing with the different side-effects …
Loss of appetite. [Targeted drug] seems to have change[d] my taste buds. I am unable to taste food any longer ….
Getting fed up of having to deal with [many] side-effects [of targeted drug] knowing it is ongoing …
If not for the side effects of the drug … I am not aware that I have lung cancer because there is no sign of it being there ….
All the side effects … occur everyday …
… Now my life seems to be governed by Cancer … eg trying to manage side-effects of drug to make life more comfortable. The most frustrating thing is, there is no end to this (seemingly).
Today I have decided to discuss with the oncologist … stop taking [treatment drug] and bear the consequences of the disease – death. I find no purpose in suffering the side-effects of the drug when I do not have a purpose to live. To doctors, my side-effects appear to be very slight in comparison to other sufferers, but to have to endure the same things day in day out with no real outcomes is hard to take.
[Cancer] does not affect me at all. I sometimes forget that it is there. If not for the side-effects of the drug, I am quite normal … Side-effects cause continuous pain + discomfort with no end in sight … I do not want to live this type of life …
… if anyone hasn’t walked in the shoes of the other, they can never understand. … it is like a disease by itself! … I do not want to lead this sort of life any longer. (Female, 67, with Metastatic Lung Cancer)
It was clear from Wendy’s experience, and other diaries, that day-to-day coping with medication and side-effects often represented the primary struggle of living with advanced cancer. That is, it often seemed almost surprising to participants that the cancer (or expectations around what cancer should feel like) was much less of an impediment to daily life than the regimens of treatment. Indeed, and as with scans, therapeutic regimens were another form of haunting – a persistent reminder of disease and the associated (and often ever-changing) affective entanglement with cancer (fight it, accept it, avoid it, forget it, and so on). Here we note a symptomological ambiguity; a collapsing of cancer/symptom/side-effect into a singular multi-headed ghost. But the pain and discomfort of everyday life under treatment also served as an ontological and relational battleground. To what extent could (or should) the body, the person, tolerate debilitating side-effects for the sake of securing more (waiting) time? And for whom? The diaries reflected feelings of worth and responsibility – evolving self-assessments of quality of life under treatment – where the day-to-day undulations of side-effects challenged participants’ evaluations of continuing life with cancer as worthwhile.
The diaries revealed questions around the lived experience of diminishing returns, and the extent to which a person was living with cancer or living with treatment. Against this background, waiting itself took on various affective alignments. For Des, below, waiting is inflected at once with the hope that things will get better and with frustration at the enduring nature of treatment side-effects:
Day 1: 14 months since given the news [of cancer] … last week of treatment … Very tired … The underlying hope is that the treatment is working and that it is a ‘curative’ approach.
Physically and emotionally, I feel down today … At this stage ‘living with cancer’ is overtaken by ‘living with the effects of cancer treatment.’
Physically: Very tired. The shortness of breath seems to be getting worse. The smallest physical activity appears to bring on the need to sit down and rest.
Still the same side effects of the treatment affecting me – tiredness, shortness of breath and sore throat.
Today is the appointment with [medical oncologist] The morning was spent examining my side effects and preparing to ask him about them. After our discussions with [oncologist], we both felt much more positive. Our appointment … went well with all my current side effects being ‘normal’.
… We are playing a waiting game … Aside from the treatment side effects, the only way I know I have cancer is what I am told as I do not have any symptoms … Probably the hardest aspect of living with cancer is accepting that I have cancer … While I have seen the results of CT and PET scans showing cancer tumors in my chest, I have had no symptoms or even discomfort … Of course I have the medical diagnosis from the various doctors and specialists. Logic and my brain tells that I have the dreaded disease but I find it difficult to accept it. (Male, 72, with Locally Advanced Lung Cancer)
As with many of the participants, Des’s experience of living with advanced cancer was dominated by the effects of treatment for cancer – the side-effects of chemotherapy and radiotherapy – as well as by logistics of medical tests, consultations and care. Here the spectre of cancer/symptom/side-effect takes on a physical presence: it haunts his body through the embodied consequences of its attempted eradication – it makes itself known through the shortness of breath, the sore throat and oppressive tiredness that are lived and felt as ‘normal’ side-effects of treatment for cancer. While Des expresses his underlying hope that the treatment will ‘work’ and, in the end, offer a ‘curative approach’, living with the spectre of cancer in the meantime offers considerably compromised conditions of possibility.
Discussion
Much of the considerable previous scholarship on cancer provides many points of continuity with the analysis offered here (e.g. Broom, Adams, & Tovey, 2009; Broom & Tovey, 2007; Bell, 2010, 2013; Chapple & Ziebland, 2002; Chapple et al., 2004; Frank, 2003; Jain, 2007; Saiillant, 1990; Sinding & Gray, 2005; Sinding et al., 2002; Stacey, 1997; Stacey & Bryson, 2012). We add to this work a further emphasis on the temporal dimensions of everyday life with cancer (see also Del Vecchio-Good et al., 1994; Jain, 2007), paying particular attention to dilemmas of knowing, affective relations with expertise, and the phenomenology of illness within the atmosphere of survivorship. We highlight the tensions ‘in between’ cancer trajectories, oncological landscapes and broader cultural atmospheres in which waiting is anathema, hauntings are often unspeakable and survival is paramount. The diaries revealed tussles provoked by living with illness – around the velocity of social life and the pace of disease and treatment, around waiting for things to get better (or get worse) and managing side-effects in the meantime, between the prognostications of medical expertise and the embodied reality and symptomatology of ill-health, and between enacting the normative vision of cancer survivorship and reclaiming a sense of normalcy in day-to-day life. These tussles, we argue, arise in the temporal dislocations and logistical minutiae of the everyday of cancer, which have been under-emphasised in previous literature. In the seemingly pedestrian of everyday life, we see the consequences of enduring normative affectivities, discursive constructions and cultural imaginaries of everyday practices of survivorship, illustrated in the stories recounted here.
Waiting emerged as a particularly important theme, prompting us to follow Schweizer (2008), among others, in considering the temporal aspects of life with cancer (Bell, 2013; Del Vecchio-Good et al., 1994; Jain, 2007). How do we wait with cancer; must we wait for it/with it; how (and when) will the waiting end; what is waiting; how do we experience time while waiting (see also Hage, 2009)? In the context of cancer, waiting became a form of temporal and normative dislocation – a forced, though often partial, removal from the steady velocity of normal social existence and productive citizenship, and one that participants often hoped would be temporary; many wanted not to wait and to return, instead, to their ‘normal’ or ‘productive’ existence. For some, waiting entailed a unique ‘existential predicament’:
Between hope and resignation, boredom and desire, fulfilment and futility, waiting extends across barren mental and emotional planes. Those who wander in it or through it find themselves in an exemplary existential predicament, having time without wanting it. (Schweizer, 2008, p. 2)
Our participants also recounted a normativity to waiting; while waiting was neither chosen nor explicitly prescribed, it was nonetheless expected (‘you must wait’, ‘you must rest’, ‘you must get better/survive’). The content of waiting – what occupied participants in the meantime – was revealed by the diaries to be a complex set of things containing varying forms of affect, agency, resistance, power and authority.
As mentioned, Gordon’s (2008, 2011) notion of hauntings helps illuminate what occupied participants’ waiting. But this, too, leads to a series of questions: by what, exactly, were they haunted; how did this haunting manifest and with what consequences? Here, we saw the hauntings of medical knowing and expertise and the forms of bodily occupation that emerge from ontological assemblages of authoritative epistemologies, somatic experiences of malady and cultural expectation around cancer survivorship. In interrogating the omnipresence of the clinical in the everyday lived experience of cancer, we do not seek to question the utility or desirability of oncological ontologies or prognostication, but rather to complement them by examining the various complexities of lived experience. And it is here, in the lived experience (as chronicled by our participants) that such hauntings became apparent and the spectres emerged. Spectres of clinical prognoses hung above participants and often subsumed their ambitions, desires and hopes, entrapping daily life within cycles of medical surveillance. Through these accounts, we posit that the waiting with cancer entails struggle among forms of knowing; the biomedical haunting of the everyday of life with cancer.
At the same time, we emphasise that the dairies illustrate the inherently mixed feelings of participants in relation to medical expertise and the therapeutic encounter. The palpable relief of the scan (when it shows no disease progression), the positive facets of learning about no new metastases during a clinical encounter, and the strength of desire to vanquish disease and achieve remission are also evident. There was also a desire for goals or targets, which required surveillance against which to show ‘progress’ or ‘successes’. Any notion of success, though, is necessarily situated within a set of particular values and priorities. The privileging of time (and cure) and the downplaying of symptomatology and quality of life are two key examples that emerge from these diaries. Waiting, we argue, is situated between the implicit values of biomedicine and what is valued in the everyday. In instances where these do not align, there emerge affective tensions around illness and care. The notion of hauntings, then, helps illuminate the dominance of particular orientations over others and the subtle ways in which power is revealed in the everyday. Statements like ‘I am told [I have cancer]’, or the idea of ‘not feeling’ cancer, which were repeated throughout various participants’ reflections, illustrate this primacy of medical expertise and its dominance over lived experience. Gordon, sensitive to the complex operation of power in instances like hauntings, characterises it thus:
Power can be invisible, it can be fantastic, it can be dull and routine. It can be obvious … it can feel like remote control, it can exhilarate like liberation, it can travel through time, and it can drown you in the present … it can harm you without seeming ever to touch you. It is systematic and it is particularistic and it is often both at the same time. It causes dreams to live and dreams to die. (2008, p. 3)
Like Gordon, we call attention to the contradictory effects of power: it is not simply a matter of medical discipline, expertise and surveillance. Power has mixed effects, being at once exhilarating and oppressive. This was evident within the diaries as we see the mixed experience of disease and treatment, how it can ‘drown you in the present’ (Gordon, 2008, p. 3). For advanced cancer patients, their relationship to authority and expertise is necessarily complex and even fraught with resistance to incurable trajectories, elision by typical cancer categorisations (curable/palliative), and often hopes (against the ‘odds’) for remission (McKenzie & Crouch, 2004). This level of complexity requires that we ask questions about what it is like for these groups of people; how they relate to (available) expertise and how this assemblage may simultaneously offer both potential and problematics. In chronicling their stories of cancer they weave between their own views and those that are available for them (i.e. biomedical ontologies); challenging and holding onto the (made) visible and the (made) concrete.
A final point: we see an additional layer of tension in the relationship between ‘incurable’ survivor with categorical liminality and broader oncological and cultural terrain. That is, perhaps our participants themselves haunt the oncological field -– as the failed subjects of oncology, the un-survivors, the unruly class of civil disobedience in an otherwise (seemingly) ordered field of ‘curable’ or ‘palliative’. Consider that our participants are concurrently imagining futures not well recognised in oncological forecasting, or indeed, rejecting futures based on assessments of the potential of their lives. Perhaps they are the true spectres in the emerging oncological terrain, offering a challenge to the priorities and values of expertise, and with whom the field of oncology may yet have to reckon.
Footnotes
Acknowledgements
The authors gratefully acknowledge the interview participants and the financial support of the Australian Research Council.
Funding
Funding for this research was provided by an Australian Research Council Discovery Grant (DP150100414) and an Australian Research Council DECRA Fellowship (DE150100285).
